发明公开
- 专利标题： Proteosome influenza vaccine composition
- 专利标题（中）： 蛋白酶体流感病毒疫苗成分
-
申请号： EP06013179.4申请日： 2001-02-15
-
公开(公告)号： EP1721618A3公开(公告)日： 2007-01-10
- 发明人: Burt, David S. , Lowell, George H. , White, Gregory Lee , Fries, Louis F., III , Jones, David Hugh , Torossian, Kirkor , Plante, Martin
- 申请人： ID Biomedical Corporation of Quebec
- 申请人地址： 7150 Frederick Banting, Suite 200 Ville St. Laurent, Québec H4S 2A1 CA
- 专利权人： ID Biomedical Corporation of Quebec
- 当前专利权人： ID Biomedical Corporation of Quebec
- 当前专利权人地址： 7150 Frederick Banting, Suite 200 Ville St. Laurent, Québec H4S 2A1 CA
- 代理机构： Wombwell, Francis
- 优先权： US182476P 20000215
- 主分类号： A61K39/39
- IPC分类号： A61K39/39 ; A61K39/145 ; A61K39/12 ; A61K39/295 ; A61P31/12 ; A61P31/16
摘要：
Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza IIA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included
公开/授权文献
- EP1721618A2 Proteosome influenza vaccine composition 公开/授权日：2006-11-15
信息查询
